retatrutide visceral fat Subcutaneous Loss Results: What Clinical Trials Reveal About Effectiveness and Safety Retatrutide: A Triple Agonist Shaping

So they're actually really, really different

With rising pet obesity rates and the pet industrys growing pharma plus nutrition strategy, theres a spark fueling interest in GLP-1 for pets, creating a new niche in the pet health market

GLP-1 medications are a class of medications called GLP-1 receptor agonists that act on natural hormone pathways in the body

SubQ technique matters

Thus, despite FDA announcing the end of the GLP-1 drug shortage in March 2025 and setting May 22 as the last day when compounded versions could be sold, the large-scale production of compounded GLP-1s continues unabated

Ito D, Shimizu S, Inoue K et al (2017) Comparison of Ipragliflozin and Pioglitazone Effects on Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Randomized, 24-Week, Open-Label, Active-Controlled Trial